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Introduction
Failure of axon regeneration in the adult central nervous system
(CNS) is due to both a muted response of CNS neurons to axon
injury and a CNS environment that is hostile to axon growth.
Myelin-based proteins, such as Nogo, MAG and OMgp,
together with chondroitin sulfate proteoglycans (CSPGs) in
the glial scar, are two major categories of CNS inhibitory
molecules demonstrated to impede axon regeneration after
injury (for a review, see David and Lacroix, 2003). Data from
several studies demonstrate that Nogo, MAG and OMpg block
axon growth by binding to their common receptor complex that
includes NgR, p75/TROY and Lingo (Liu, B. P. et al., 2002;
Mandemakers and Barres, 2005; Mi et al., 2004; Park et al.,
2005). Recent studies indicate that the inhibitory effects of
these myelin-based molecules are mediated by Rho activation
downstream of PKC (Sivasankaran et al., 2004), p75-TROY
(Mandemakers and Barres, 2005; Park et al., 2005; Yamashita
et al., 2002), and probably EGFR activation induced by
calcium influx (Koprivica et al., 2005). As a result, inhibition
of these signaling mediators is able to antagonize the effects of
myelin-based inhibitors. By contrast, the mechanisms by
which CSPGs block axon growth are less clear because no
CSPG receptor has been identified. Early studies suggested that
CSPGs may impede axon growth through interfering with
extracellular matrix (ECM)-integrin interactions (McKeon et
al., 1995; Smith-Thomas et al., 1994). Indeed, endogenous
upregulation as well as overexpression of integrin has been
shown to promote axon growth on CSPG (Condic, 2001;
Condic et al., 1999). However, recent studies suggest that
CSPG may inhibit axon growth by similar mechanisms to those
of Nogo, MAG and OMgp through Rho activation (Monnier et
al., 2003; Sivasankaran et al., 2004).
Axon growth requires both gene transcription for the
synthesis of raw materials and coordinated assembly of
cytoskeletal elements in the extending axon. CNS inhibitory
molecules are thought to act primarily at the growth cone to
shut down axon assembly. Axon assembly is a highly regulated
process strongly influenced by extracellular factors during both
development and successful peripheral nervous system (PNS)
regeneration (Kuruvilla et al., 2004; Patel et al., 2000; Werner
et al., 2000). Two well-studied groups of extracellular factors
that mediate axon assembly are neuronal growth factors, such
as neurotrophins, and adhesion proteins, which include ECM
proteins and cell adhesion molecules (CAMs). Recent in vitro
studies of highly purified neurons in defined media indicate
that either neurotrophins or ECM proteins alone induce only
limited axon growth from either PNS or CNS neurons during
development (Goldberg et al., 2002; Lentz et al., 1999; Liu,
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R. Y. et al., 2002). However, neurotrophins and ECM together
induce robust axon growth (Goldberg et al., 2002; Liu, R. Y.
et al., 2002), suggesting that coordinated activation of
neurotrophin and ECM-integrin signaling is necessary for
efficient and long-distance axon extension. CNS inhibitory
molecules could block axon assembly by interfering with either
signaling cascades that drive axon assembly induced by
extracellular factors, or the intracellular machinery that
assembles axons, or both. Most previous studies have focused
on how CNS inhibitors affect the intracellular axon assembly
machinery in the absence of extracellular axon-promoting
factors. Less attention has been paid to the interaction between
CNS inhibitors and axon growth-promoting signaling activated
by extracellular factors.
In this study, we investigated the effects of Nogo and
aggrecan on axon assembly of adult dorsal root ganglion
(DRG) neurons promoted by either nerve growth factor (NGF)
treatment or a pre-conditioning lesion (PCL) in the presence of
ECM laminin. We have found that Nogo has no effect on either
NGF or PCL-induced axon assembly when DRG neurons are
cultured on laminin. By contrast, aggrecan significantly blocks
both NGF and PCL-induced axon assembly in the presence of
laminin. Surprisingly, we found that the addition of NGF
overcomes the inhibitory effect of aggrecan and induces robust
axon assembly of PCL neurons over CSPGs. We also
discovered that, unlike naive neurons that require simultaneous
activation of both growth factor and integrin pathways for axon
assembly, either growth factor or ECM-integrin signaling alone
is sufficient to induce axon assembly of PCL neurons.
Furthermore, NGF mediates axon assembly of PCL neurons by
a distinct ECM-integrin independent pathway, suggesting that
NGF can overcome the inhibitory effect of aggrecan by
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bypassing the requirement of ECM-integrin signaling for axon
growth in PCL neurons. Finally, we show that the previously
identified GSK-3–APC pathway is a convergent point for
axon assembly of PCL neurons induced by both NGF and
ECM-integrin. Taken together, our data provide new insight
into the mechanisms of CNS inhibitory molecules, and thus
suggest a new direction to achieve axon regeneration over a
hostile CNS environment.
Results
Different effects of Nogo and aggrecan on axon
assembly from adult DRG neurons
Most studies of CNS inhibitory molecules have examined their
effects on developing neurons in the absence of extracellular
signals that promote axon assembly (e.g. on poly-D-lysine in
the absence of neurotrophic factors). Since extracellular axon-
promoting factors are required for efficient axon growth, it
is of considerable interest to study the effects of inhibitory
molecules on adult, especially regenerating neurons, in the
presence of defined signals promoting axon growth (e.g. NGF,
ECM, etc.). We first tested how Nogo affects axon assembly
from adult naive DRG neurons cultured on laminin in the
presence of NGF. Our results showed that Nogo had no
inhibitory effect on NGF-induced axon assembly from adult
naive DRG neurons plated on laminin (Fig. 1A). Additionally,
regenerating adult DRG neurons primed with conditioning
lesions and plated on laminin were also able to overcome the
inhibitory effect of Nogo (Fig. 1A). These results are consistent
with earlier studies showing that signaling events activated by
laminin can abolish the inhibitory effect of CNS myelins
(David et al., 1995), and a more recent study that laminin
overrides the inhibitory effect of MAG (Laforest et al., 2005).
Fig. 1. Aggrecan and Nogo affect axon assembly from
adult DRG neurons differently in the presence of
extracellular axon promoting factors. (A) When adult
DRG neurons (both naive and PCL neurons) were
cultured on laminin (LM), treatment with the CNS
myelin inhibitor Nogo had no effect on axon
assembly. (B) NGF-induced axon assembly from adult
naive DRG neurons plated on laminin was markedly
inhibited by aggrecan. (C,D) Quantification of the
inhibitory effect of aggrecan (Agg.) on axon assembly
from adult naive neurons (C) and PCL neurons (D).
Values are means ± s.e.m. *P<0.0001 compared with
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In significant contrast, aggrecan, a component of CSPGs,
significantly abolished NGF-induced axon assembly of naive
neurons cultured in the presence of laminin (Fig. 1B,C).
Immunostaining (supplementary material Fig. S1) showed that
NGF-induced ERK phosphorylation was not affected by
aggrecan, suggesting that ECM-integrin signaling is probably
the major target of CSPGs (McKeon et al., 1995). Further, PCL
neurons plated on a mixture of laminin and aggrecan also
exhibited minimal axon growth (Fig. 1D). To determine whether
other CSPGs had similar growth inhibitory effects we plated
PCL neurons on a commercially available mixture of CSPGs.
Similar inhibitory effects were observed when a mixture of
CSPGs was used instead of aggrecan (data not shown). These
data are in agreement with previous results that regenerating
neurons triggered by cell dissociation (axotomy) cannot
overcome the inhibitory effect of CSPGs of the glial scar (Davies
et al., 1997). Taken together, our results show that in the presence
of signals promoting axon growth, myelin-based inhibitors and
CSPGs act through distinctly different pathways to interfere with
local signaling events that regulate axon assembly.
NGF but not Rho inactivation stimulates robust axon
assembly from PCL neurons on CSPG
It is unclear how CSPGs block axon assembly, because no
CSPG receptor has been identified. Recent studies suggest that
CSPGs may inhibit basal axon assembly in the absence of
extracellular signals by activation of Rho, EGFR or PKC,
similar to the mechanism of Nogo, MAG and OMgp
(Koprivica et al., 2005; Monnier et al., 2003; Sivasankaran et
al., 2004). In fact, treatment of neurons with pharmacological
inhibitors of Rho, PKC or EGFR completely rescued the basal
axon assembly inhibited by CSPGs.
To examine whether similar mechanisms mediate the
inhibitory effect of aggrecan on axon assembly of adult DRG
neurons in the presence of axon-growth-promoting factors, we
treated adult naive neurons with Rho kinase inhibitor Y27632.
We found that the Rho kinase inhibitor did not overcome the
inhibitory effect of aggrecan (Fig. 2A). A similar result was
observed when a dominant-negative RhoA construct was
expressed in naive neurons (data not shown). Similarly,
addition of Y27632 to PCL neurons plated on aggrecan did not
rescue axon assembly (Fig. 2B). These results indicate that
axon assembly of adult neurons in the presence of extracellular
factors can be inhibited by CSPGs and that Rho inactivation
alone is not sufficient to reverse this axon growth inhibition.
Neurons treated with PKC or EGFR inhibitors also did not
show rescued axon assembly under similar experimental
settings (data not shown). Moreover, previous studies have
suggested that elevation of cAMP levels may underlie
peripheral injury-induced intrinsic changes of DRG neurons
that allow axon assembly on myelin-based inhibitory
molecules (Neumann et al., 2002; Qiu et al., 2002). We
therefore tested whether naive adult neurons in the presence of
elevated cAMP could overcome aggrecan and grow axons. Our
results showed that treating cells with db-cAMP did not
promote axon assembly from naive adult neurons cultured on
aggrecan (Fig. 2A). Taken together, these data further suggest
that CSPGs inhibit extracellular-signal-induced axon assembly
by different mechanisms to that of myelin-based inhibitors.
Surprisingly, when we added NGF to PCL neurons cultured
on aggrecan, it significantly restored axon growth (Fig. 3A-E),
even though NGF was unable to initiate axon assembly in naive
neurons cultured on aggrecan (see Fig. 1B). The average axon
length and the percentage of neurons with axons are similar to
those of control neurons on laminin (Fig. 3D,E). Addition of
other neurotrophic factors, NT3 and GDNF, together with NGF
further increased the percentage of neurons that extend axons
over aggrecan (data not shown). To determine whether these
effects of NGF are through activation of the TrkA receptor
followed by PI3K activation, neurons were treated with a TrkA
receptor antagonist K252a. Axon growth from neurons treated
with NGF and K252a cultured on aggrecan was significantly
decreased. The phosphoinositide 3-kinase (PI3K) inhibitor,
LY294002, had an even greater effect preventing NGF-induced
growth on aggrecan (Fig. 3D,E). These results clearly
demonstrated that adult regenerating neurons are able to
overcome glial scar inhibitors when a neurotrophic pathway is
activated. Axon growth of PCL neurons on laminin has been
shown to be independent of transcription (Smith and Skene,
1997). The NGF-induced axon growth of PCL neurons over
aggrecan was also transcription independent, as the
transcription inhibitor DRB showed no inhibitory effect (Fig.
3E). Finally, a 1 integrin function-blocking antibody showed
no effect on NGF-induced axon growth of PCL neurons (Fig.
3E), indicating that NGF induces axon growth over aggrecan
by an integrin-independent pathway.
PCL allows adult DRG neurons to extend axons in
response to either ECMs or NGF alone
In order to determine how a conditioning lesion allows
neurotrophic factors to promote axon assembly of PCL neurons
Fig. 2. Neither acute elevation of cAMP nor inhibiting Rho kinase
activity is sufficient to overcome the inhibitory effect of aggrecan on
axon assembly from adult DRG neurons. (A) Neither addition of
dbcAMP (1 mM) nor addition of Y27632 (25 M) induced axon
growth from naive neurons cultured on aggrecan and laminin in the
presence of NGF. (B) Addition of the Rho kinase inhibitor Y27632
had little effect on axon assembly from the PCL neurons cultured on













but not naive neurons over CSPGs, we compared how
extracellular signals mediate axon assembly from naive or PCL
adult DRG neurons.
We took advantage of the fact that there is a 24-hour window
in which to study axon assembly from naive neurons. Longer
culture times mimic axotomy effects and switch naive neurons
into a regeneration mode similar to PCL neurons (Smith and
Skene, 1997). Our results demonstrate that similar to the case
for embryonic DRG neurons (Liu, R. Y. et al., 2002), NGF and
laminin are both required as extracellular signals to mediate
efficient axon assembly from naive adult DRG neurons
(supplementary material Fig. S2). NGF or laminin alone were
unable to induce significant axon outgrowth in naive neurons
cultured for 24 hours. Importantly, experiments with a
transcription inhibitor verify that there is a requirement for NGF
in axon growth that is independent of its effects on gene
transcription.
We then examined how axon assembly of PCL neurons was
regulated. We found that no significant axon growth occurred
in 24 hours when PCL neurons were cultured in the absence
of any extracellular factors (on poly-D-lysine in serum-free
medium). However, in significant contrast to naive neurons,
when PCL neurons were plated in serum-free medium on
laminin, long-distance axon growth occurred from roughly
45% of neurons (Fig. 4A-C). Presumably the other 55% of the
DRG neurons that do not extend axons during the 24-hour
period were either not axotomized by transection of the sciatic
nerve, or extend axons so slowly that significant growth does
not occur over this time frame. Interestingly, other ECMs, such
as fibronection and tenascin C, were also able to induce axon
growth (data not shown). However, L1 CAM, a non-integrin-
mediated adhesion protein could not support significant axon
growth from PCL neurons (supplementary material Fig. S3),
suggesting a specific role of ECMs in mediating regenerative
axon growth from adult DRG neurons. When we examined
PCL-induced axon assembly in the presence of the 1 integrin
function-blocking antibody, it significantly impaired axon
assembly induced by laminin, whereas the control IgG protein
had little effect (Fig. 4D), indicating that ECMs induce axon
growth from PCL neurons through the activation of integrin
signaling. To rule out the possibility that neurotrophins
secreted by the neurons themselves mediate the axon assembly,
the Trk inhibitor K252a was added to the medium. Results
showed that K252a had no effect on regenerative axon growth
(Fig. 4C), even though the same concentration of K252a
significantly blocked NGF-mediated axon assembly. Together,
these results indicate that axon growth of PCL neurons on
laminin is mediated by the activation of integrin signaling
alone.
To determine whether other growth factor signaling pathways
can mediate axon assembly from PCL neurons, we screened
various polypeptide growth factors in the absence of integrin
activation. When NGF was added to the medium, we saw a
significant increase in the percentage of PCL neurons that were
Journal of Cell Science 119 (13)
Fig. 3. Activation of neurotrophin signaling is able
to overcome the inhibitory effect of aggrecan on
axon assembly from PCL neurons. (A,B) Laminin-
induced axon assembly from PCL neurons (A) was
markedly inhibited by aggrecan (B). (C) Addition of
NGF overcame the inhibitory effect of aggrecan on
axon assembly from PCL neurons. Magnification,
4. (D,E) Quantification of the stimulatory effect of
NGF on axon assembly from PCL neurons cultured
on aggrecan. Note that the rescue effect of NGF
depends on the activities of TrkA and PI3K,
mediators of the NGF signaling, but is independent
of integrin signaling and transcription (E).
*P<0.0001 vs control; **P<0.0001 between
indicated groups in D, and vs LM+NGF+Agg. in E.
#P<0.01 vs LM+NGF+Agg. in D and E. DRB,
transcription inhibitor; K252a, TrkA inhibitor; LY,











2791Neurotrophins support regenerative axon assembly over CSPG
able to extend long axons on poly-D-lysine (Fig. 4A). The
percentage of neurons with axons includes the neurons that
respond to both axotomy and NGF. In addition to NGF, NT3 and
GDNF were also capable of promoting axon assembly from PCL
neurons (data not shown), whereas the addition of IGF or EGF
that also act through receptor tyrosine kinases did not support
axon growth from these neurons (Fig. 4E). Additionally, the
growth-promoting effect of NGF was TrkA dependent because
K252a significantly attenuated NGF-induced axon assembly
(Fig. 4E). When axon length was measured, we found that NGF
could induce axon assembly from the PCL neurons to the same
extent as that induced by laminin alone (Fig. 4F). Both integrin
activation and NGF stimulation have been shown to inactivate
RhoA (Arthur and Burridge, 2001; Yamashita et al., 1999),
however when regenerating neurons were treated with a Rho
kinase inhibitor Y27632 alone, little axon assembly was induced
when compared with NGF or laminin treatments (Fig. 4F). This
result suggests that inactivation of RhoA by itself is not sufficient
to mediate the axon-promoting effects of integrin or NGF
stimulation.
Since ECM-integrin is a major target of CSPGs, together our
data suggest that the ability of NGF to promote axon assembly
of PCL neurons over CSPGs is due to the fact that PCL allows
neurons to extend axons in an ECM-integrin independent
manner in response to NGF.
NGF and ECM-integrin signaling mediate axon assembly
of PCL neurons by divergent signaling pathways
We next determined whether growth factor or integrin
activation require the same downstream signaling mediators to
promote axon assembly of PCL neurons. We first examined a
series of pharmacological inhibitors to determine their effects
on axon assembly of PCL neurons. We found that NGF-
mediated axon assembly of PCL neurons requires classical
PI3K and PKC activities (Fig. 5A). In significant contrast,
ECM-integrin-mediated axon assembly from PCL neurons is
independent of PI3K, the major signaling mediator of
neurotrophins, but requires atypical PKC and Src activity (Fig.
5B). To confirm the fact that integrin-mediated axon assembly
from PCL neurons does not depend on PI3K, we overexpressed
a dominant-negative form of PI3K, previously shown to block
NGF-induced axon assembly from embryonic neurons
(Markus et al., 2002b), in PCL neurons. Results showed that
dominant-negative PI3K had no effect on axon assembly from
PCL neurons induced by laminin (Fig. 5C). We also tested
whether Raf, another major signaling mediator of NGF, is
required for ECM-integrin induced axon assembly of PCL
neurons by expressing a dominant-negative form of C-Raf that
is sufficient to block NGF-induced axon assembly (Markus et
al., 2002b). We found that Raf activation was not required for
ECM-integrin mediated axon assembly from PCL neurons
Fig. 4. Either laminin or NGF alone is sufficient to
mediate axon assembly from PCL neurons. (A) PCL
neurons were unable to extend axons when cultured on
poly-D-lysine (PDL) in the absence of extracellular cues.
Neurons plated on laminin-coated coverslips extended
axons robustly. (B) Neurons did not extend axons when
cultured on poly-D-lysine-coated coverslips in serum-free
medium. Addition of NGF induced robust axon assembly
from the PCL neurons on poly-D-lysine. Magnification,
4. (C) Quantification of laminin-induced axon assembly
from PCL neurons. Please note that the addition of
laminin (S, 20 g/ml) directly to the culture medium
induced a similar extent of axon assembly to that of
coated laminin (C). Laminin-induced axon growth was
independent of the neurotrophin receptor Trk activity.
*P<0.0001 vs control. (D) Laminin-induced axon growth
was significantly blocked by an integrin function-blocking
antibody (20 g/ml), whereas control IgG protein had no
effect. *P<0.0001 vs control. (E,F) Quantification of
NGF-induced axon growth from the PCL neurons. Note
that other growth factors, such as EGF and IGF, failed to
induce axon growth. In addition, inactivation of Rho
kinase with inhibitor Y27632 (25 M) had minimal effect
on inducing axon assembly from the PCL neurons, only
slightly enhancing basal axon growth. *P<0.005 and












(Fig. 5D). Finally, the requirement of Src for integrin-mediated
axon growth was confirmed with a dominant-negative Src
construct (Fig. 5E). These results indicate that neurotrophins
and ECMs use distinct signaling mechanisms to mediate axon
assembly of PCL neurons. Consistent with these functional
data, western blot results showed that PI3K and ERK pathways
were not activated in PCL neurons upon laminin stimulation
(Fig. 6G). Together, these results suggest that, in PCL neurons,
ECM-integrin mediates axon assembly by different pathways
to NGF. As a result, CSPGs can specifically block ECM-
integrin-induced axon assembly while having no effect on
NGF-mediated axon assembly of PCL neurons.
Previously we showed that integrin-linked kinase (ILK)
mediates NGF-induced axon assembly from embryonic DRG
neurons downstream of PI3K (Zhou et al., 2004). We therefore
examined whether ILK activity was also required for
regenerative axon growth from adult PCL neurons. Application
of a specific ILK kinase inhibitor KP74728 significantly blocked
both NGF and laminin-induced axon assembly from PCL
neurons (Fig. 5A,B), indicating that ILK is a converging
signaling mediator in these neurons. Consistent with an
important role of ILK, the protein level of ILK was significantly
increased in DRGs after peripheral axotomy (data not shown). 
We have shown previously that NGF can mediate axon
assembly by the regulation of localized inactivation of GSK-
3 and the interaction of APC with microtubules downstream
of ILK and PI3K. Similar localization of inactivated GSK-3
and APC was observed at the distal tips of regenerating axons
(Zhou et al., 2004), suggesting that the GSK-3–APC pathway
may also play an important role in regulating regenerative axon
assembly in PCL neurons. To investigate whether inactivation
of GSK-3 and the subsequent APC-microtubule interactions
are necessary for axon assembly of PCL neurons plated on
laminin, we expressed constructs that interfere with this
pathway to determine how they affect laminin-induced axon
assembly of PCL neurons. Results showed that expression of
a control EGFP construct had little effect on axon assembly
(Fig. 6A). By contrast, overexpression of a mutant GSK-3,
GSK-3(S9A), which cannot be phosphorylated at Ser9,
significantly blocked regenerative axon growth induced by
laminin (Fig. 6B,E). This result indicates that inactivation of
GSK-3 by phosphorylation is necessary for laminin to induce
axon assembly from the PCL neurons. Consistent with this
idea, plating PCL neurons on laminin increased GSK-3
phosphorylation, whereas laminin alone was not sufficient to
induce GSK-3 phosphorylation in naive and embryonic DRG
neurons in the absence of NGF (Fig. 6G). Finally, we examined
whether the interaction between APC and microtubules is also
required for integrin-mediated axon assembly. To interrupt this
interaction, we overexpressed a mutant EB1 (C-EB1) that can
sequester endogenous APC (Zhou et al., 2004). We found that
C-EB1 almost completely abolished integrin-induced axon
assembly from regenerating neurons (Fig. 6C,F), whereas C-
EB1 lacking the APC binding domain had little effect (Fig. 6D-
F). Together, these results indicate that the GSK-3–APC
pathway is a converging point for both ECM-integrin- and
NGF-induced regenerative axon growth of PCL neurons. 
Discussion
In this study, we examined how two CNS inhibitory molecules,
Nogo and aggrecan, affect axon assembly of naive and
regenerating adult DRG neurons in the presence of
extracellular factors that promote axon assembly. Under these
experimental settings, we find that Nogo and aggrecan affect
Journal of Cell Science 119 (13)
Fig. 5. ECM-integrin and neurotrophin signaling mediate axon assembly from PCL neurons by different signal pathways. (A) NGF-induced
axon assembly from the PCL neurons was significantly inhibited by specific inhibitors of PI3K (LY294002, 20 M), classical PKC (Go6976,
200 nM), general PKC (BIS, 10 M), Src (PP1, 10 M) and ILK (KP74728, ILKi, 20 M). *P<0.0001 vs control. (B) In contrast to NGF-
induced axon assembly, neither the specific PI3K inhibitor wortmannin (200 nM) nor the classical PKC inhibitor Go6976 (200 nM) inhibited
laminin-induced axon assembly of the PCL neurons. Similarly to NGF-induced axon assembly, laminin-induced axon assembly of the PCL
neurons was significantly inhibited by the PKC inhibitor BIS (10 M), the specific Src inhibitor PP1 (10 M), and the specific ILK inhibitor
KP74728 (20 M). *P<0.0001 vs control. (C) Expression of a dominant-negative (DN) PI3K construct had no effect on laminin-induced axon
extension from PCL neurons. (D) Expression of a dominant-negative C-Raf construct had no effect on laminin-induced axon extension from
PCL neurons. (E) Expression of a dominant-negative Src construct significantly inhibited laminin-induced axon extension from PCL neurons.
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axon assembly of adult DRG neurons quite differently. Our
data suggest that aggrecan interferes with an ECM-integrin-
mediated extracellular signal that promotes axon assembly
(Fig. 7). Thus, CSPGs inhibit axon assembly mediated by
ECM-integrin signaling, which is necessary for axon assembly
of developing and naive adult DRG neurons. However, a pre-
conditioning lesion induces intrinsic changes in neurons so that
PCL neurons are able to support ECM-integrin-independent
axon assembly. As a result, neurotrophins can bypass the
ECM-integrin signaling and promote axon assembly of PCL
neurons in the presence of CSPGs (Fig. 7). Finally, we show
that both ECM-integrin and NGF promote axon assembly of
PCL neurons by a conserved GSK-3–APC pathway.
CSPGs inhibit axon regeneration by a different
mechanism to myelin-based inhibitors in the presence of
axon-growth-promoting factors
Axon extension is controlled by intracellular machinery that
assembles cytoskeletal elements and membrane components
into new axons. An intracellular signaling cascade activated by
extracellular factors is necessary to power the machinery and
drive axon assembly, even though the basal activities of
intracellular signaling molecules (e.g. kinases, second
messengers, etc.) can mediate limited axon extension in the
absence of extracellular factors. Recent studies suggest that
CSPGs inhibit basal axon growth in the absence of
extracellular signals by a similar mechanism to that of Nogo,
MAG and OMgp (Monnier et al., 2003; Sivasankaran et al.,
2004; Koprivica et al., 2005). In this study, we examined the
effects of Nogo and aggrecan on axon assembly of adult DRG
neurons in the presence of defined extracellular axon growth
factors, including neurotrophins and ECMs. Our results clearly
demonstrate that Nogo and aggrecan have different effects on
axon assembly of adult DRG neurons. 
First, when adult DRG neurons were cultured on laminin,
Nogo had no inhibitory effect on axon assembly induced by
either NGF or PCL. Since acute NGF treatment of DRG neurons
was unable to overcome the inhibitory effect of MAG when
neurons were cultured on poly-D-lysine (Cai et al., 1999), our
result suggests that laminin acts to antagonize the effect of Nogo.
Indeed, a previous observation has shown that laminin is able to
overcome the inhibitory effect of CNS myelins (David et al.,
1995). Moreover, a recent study has also demonstrated that
laminin is able to override the inhibitory effect of MAG by
regulation of Rac activity (Laforest et al., 2005).
By contrast, aggrecan significantly blocked axon assembly
under the same experimental conditions. Furthermore, in NGF-
induced axon growth, aggrecan did not affect ERK activation,
the major signaling pathway downstream of NGF. This result
indicates that NGF signaling is not a major target of aggrecan
and implies that ECM-integrin signaling is probably the major
target of aggrecan (Carulli et al., 2005; Smith-Thomas et al.,
1994). This idea is further supported by the result that aggrecan
blocked laminin-induced axon assembly of PCL neurons, as
laminin-integrin activation is the only extracellular signal that
mediates axon assembly under such conditions. The inhibitory
effect of aggrecan shown here is unlikely to be due to its ability
to directly interfere with the basic intracellular axon assembly
machinery through Rho activation (see Discussion below).
Together, the different functional effects of Nogo and aggrecan
on axon assembly shown in this study suggest that myelin-
based inhibitors and CSPGs inhibit axon assembly by different
mechanisms. This difference between myelin-based inhibitors
and CSPGs only becomes apparent when axon assembly is
induced by defined extracellular axon growth factors,
especially the ECMs. The effect of myelin-based inhibitors can
be overcome by ECM-integrin activation, whereas CSPGs act
to block ECM-integrin signaling (Fig. 7).
Second, both inactivation of Rho and elevation of cAMP
have been used to overcome the inhibitory effect of myelin-
Fig. 6. The GSK-3–APC pathway is required for
integrin-induced regenerative axon assembly from
PCL neurons. (A) Overexpression of EGFP had no
effect on integrin-mediated axon assembly.
(B) Expression of the constitutively activated
GSK-3 mutant (yellow) significantly blocked
axon assembly. (C) Axon assembly was abolished
in neurons expressing C-EB1 (yellow), a mutant
protein that interferes interactions between APC
and microtubule plus ends. (D) Axon assembly in
neurons expressing C-EB1APC was not affected.
Arrows indicate transfected cells that express GFP.
Axons of transfected neurons are yellow.
Neurofilament staining (red) reveals axons of
untransfected cells. Magnification, 4.
(E,F) Quantification of axon assembly defect in
neurons expressing the active GSK-3 mutant or
the EB1 mutant (*P<0.001 vs control).
(G) Laminin stimulation alone was sufficient to
phosphorylate GSK-3 in adult PCL neurons, but
had no effect on phospho-ERK and phospho-Akt
levels. By contrast, laminin stimulation was unable
to phosphorylate GSK-3 in embryonic day 14












based inhibitors (Fournier et al., 2003; Neumann et al., 2002;
Qiu et al., 2002). We showed that these two treatments did not
significantly rescue axon assembly of adult neurons plated on
aggrecan, further indicating that CSPGs block axon assembly
via different mechanisms from myelin-based inhibitors. Our
interpretation of these conflicting results is that the Rho-
mediated inhibitory effect mainly serves as a ‘brake’ that
inhibits the intracellular axon assembly machinery (Fig. 7).
Therefore, Rho inactivation alone is not sufficient to drive axon
assembly in the absence of axon growth-promoting signals
(e.g. NGF, laminin). We hypothesize that the effect of Rho
inactivation in promoting axon assembly on CSPG
demonstrated in previous studies from Monnier et al. (Monnier
et al., 2003) and Sivasankaran et al. (Sivasankaran et al., 2004)
are due to the fact that neurons used in those studies exhibit
limited degree of basal axon growth that is ECM-integrin
independent. Taken together, we believe our data show that
although CSPGs may impede basic axon assembly via Rho
activation, they inhibit axon growth mainly through blocking
integrin signaling (Fig. 7).
Finally, it is worth mentioning that neurons primed with PCL
have been shown to overcome the inhibitory effect of myelin-
based inhibitors (Neumann et al., 2002; Qiu et al., 2002).
However, in our study, laminin-induced axon assembly of PCL
neurons was still inhibited by aggrecan, further indicating that
CSPGs act differently from myelin-based inhibitors to block
axon assembly. This result is also consistent with in vivo
observations that transplanted adult DRG neurons (mimicking
PCL) can support robust axon growth over spinal cord myelin
but stop at the boundary of CSPGs (Davies et al., 1997).
Either integrin or neurotrophin signaling can induce axon
assembly in PCL neurons
It is well established that peripheral axotomy induces intrinsic
changes in adult DRG neurons that lead to a robust axon
regenerative response (for a review, see Snider et al., 2002).
Although numerous studies have addressed changes in gene
expression induced by axotomy (Costigan et al., 2002; Tanabe
et al., 2003), little attention has been paid to axotomy-induced
changes in the signaling events that mediate axon assembly. In
this study, we show that in striking contrast to the situation in
developing and naive neurons, which require simultaneous
activation of integrin and growth factor signaling for axon
growth, integrin activation by ECM alone is sufficient to induce
robust axon assembly of PCL neurons. Since integrin signaling
by itself is not sufficient to induce efficient axon assembly in
the absence of neurotrophic peptides in developing neurons
(for a review, see Goldberg, 2003), our study suggests that a
different integrin-mediated pathway may specifically control
regenerative axon assembly.
More importantly, we have demonstrated that robust axon
assembly from PCL neurons is induced when NGF signaling
is activated in the absence of ECM-induced integrin activation.
Thus, when PCL neurons are plated on a neutral substrate,
addition of NGF triggers axon growth similar in extent to that
which occurs when PCL neurons are plated on laminin. This
ECM-integrin-independent axon assembly is also unique
to regenerating neurons. As a result of these changes,
regenerating axons are presumably more adaptive to the local
surface molecules, which may be markedly different from
those encountered in the developing nervous system. How pre-
conditioning lesion induces such changes is unclear.
Interestingly, a similar growth phenomenon has been observed
with cancer cells. Normal cells require both growth factor
signaling and attachment to the ECM (integrin activation) for
growth. By contrast, cancer cells are able to grow in suspension
independently of integrin activation by ECMs (for a review, see
Giancotti and Ruoslahti, 1999). The idea of parallels between
signaling in regeneration and malignant transformation is
supported by recent gene-profiling studies, in which a group of
cancer-related genes was identified to be upregulated after a
peripheral nerve injury (Cameron et al., 2003).
Furthermore, our studies also demonstrate that, in PCL
neurons, ECM-integrin and NGF mediate axon assembly by
different signaling pathways. ECM-integrin-induced axon
assembly of PCL neurons does not depend on PI3K and Raf-
ERK activities, which are major mediators of NGF signaling
(for a review, see Markus et al., 2002a). However, by using a
constitutively active GSK-3 construct and overexpressing a
mutant APC binding protein, we demonstrate that the GSK-
3–APC pathway, previously shown to mediate NGF-induced
axon assembly, is also crucial for integrin-mediated
regenerative axon assembly of PCL neurons. This result
indicates that both ECM-integrin and NGF need to converge
onto the GSK-3–APC pathway to mediate axon assembly of
PCL neurons. Indeed, we show that laminin alone is sufficient
to induce GSK-3 phosphorylation of PCL neurons, further
supporting the idea that ECM-integrin and NGF mediate axon
assembly independently of each other in PCL neurons. Given
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Fig. 7. A proposed model for regulation of axon assembly of adult
DRG neurons. To promote efficient axon growth, extracellular axon
growth promoting factors are required. Adult naive neurons require
the activation of both integrin and neurotrophin signaling pathways
simultaneously for efficient axon growth. Both the CNS myelin-
based inhibitor Nogo and glial scar-based inhibitor CSPGs can
inhibit basal axon assembly by activation of Rho. However, CSPGs
and myelin-based inhibitors act differently to affect axon growth
when the extracellular axon growth promoting factors are present.
CSPGs can interfere with ECM-integrin signaling, thus preventing
extracellular factors from stimulating axon growth. On the contrary,
activation of ECM-integrin pathway is able to antagonize the
inhibitory effect of the myelin-based inhibitors. Peripheral nerve-
injury-mediated conditioning lesion separates the neurotrophin and
ECM-integrin pathways, thus allowing either ECM-integrin signaling
or neurotrophin signaling to mediate axon assembly independently.
As a result, neurotrophins can promote robust axon assembly of PCL
neurons over CSPGs by bypassing the requirement of integrin
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the importance of GSK-3–APC pathway in mediating axon
assembly of regenerating neurons, it will be interesting in the
future to investigate how it is regulated downstream of integrin
or neurotrophins in PCL neurons and whether it is the target
of different CNS inhibitors. However, these results do not
necessarily mean that the ILK–GSK-3 pathway is the only
pathway that mediates axon growth downstream of both NGF
and laminin-integrin signaling.
Neurotrophins mediate ‘regenerative’ axon assembly on
CSPGs by bypassing ECM-integrin signaling
Although much effort has been devoted to finding ways to
promote axon regeneration over inhibitory CNS molecules,
few studies have successfully induced robust axon assembly
over CSPGs, the major components of the glial scar. The main
reason is due to limited knowledge of mechanisms that
underlie the inhibitory effect of CSPGs. Although recent
studies suggest that CSPGs may use the same molecular
mechanisms as myelin-based inhibitors, in this study
treatments shown to overcome the myelin-based inhibitors
failed to rescue axon growth induced by extracellular axon-
promoting factors. By contrast, we show here, for the first time,
that neurotrophins are able to induce long axon growth of PCL
neurons in the presence of CSPGs. The rescue effect of NGF
was significant when either axon length or percentage of
neurons with axons was measured. Since our results, together
with previous observations, suggest that CSPGs can inhibit
axon assembly by interfering with ECM-integrin signaling, one
way to overcome its inhibitory effect is to induce axon
assembly by pathways independent of ECM-integrin signaling.
Indeed, we find that in PCL neurons, either ECM-integrin or
NGF can induce axon assembly independently of each other
by distinct signaling pathways. As a result, neurotrophins are
able to bypass the ECM-integrin signaling to induce axon
assembly over CSPGs. Therefore, approaches that directly
activate integrin signaling may be a potential way to promote
CNS axon regeneration over glial scar.
Another way to overcome the inhibitory effect of CSPGs
may be to increase the expression of integrins and thus their
responsiveness to ECMs (Condic, 2001; Condic et al., 1999).
Interestingly, several integrins are upregulated after sciatic
nerve injury in DRG neurons (Wallquist et al., 2004). However,
our data that PCL neurons were able to grow long axons in the
absence of any ECMs (i.e. on poly-D-lysine) suggest that
increases in responsiveness to ECMs may not explain the
conditioning lesion effect. Instead, our results suggest that the
activation of signaling mediators localized downstream of
integrin at the convergent point with growth factor signaling,
such as Src, ILK and FAK-Pyk2 (Ivankovic-Dikic et al., 2000),
might underlie the ability of NGF to promote axon assembly
of PCL neurons on poly-D-lysine or CSPGs.
We show here that GSK-3 inhibition is necessary for both
NGF and ECM-integrin signaling in PCL neurons to mediate
axon assembly, suggesting GSK-3 as a key regulator of axon
regeneration. In addition, inhibition of GSK-3 has also been
implicated in CNS regeneration by inducing multiple axons
from hippocampal neurons (Jiang et al., 2005). However,
global application of GSK-3 inhibitors on adult DRG
neurons was unable to promote axon assembly over CSPGs
(unpublished data), indicating that GSK-3 inactivation alone
is not sufficient to overcome the inhibitory effect of CSPGs, or
a localized inactivation of GSK-3 is required (Zhou et al.,
2004). Indeed, NGF-induced activation and inactivation of
GSK-3 simultaneously is necessary to ensure optimal axon
growth by regulation of different microtubule-binding proteins
(for a review, see Zhou and Snider, 2005). 
In conclusion, our data indicate that CSPGs and myelin-
based inhibitors block axon regeneration by different
mechanisms in the presence of extracellular axon-growth-
promoting factors. In addition to acting through the same
pathway as Nogo by Rho activation, CSPGs may also interfere
with extracellular axon growth promoting signaling activated
by ECM-integrin. After a peripheral conditioning lesion, adult
DRG neurons change their intrinsic properties, thus allowing
either NGF or ECMs to induce axon assembly by distinct
pathways. As a result, NGF is able to overcome the inhibitory
effect of CSPGs by bypassing the ECM-integrin signaling in
PCL neurons. Our results suggest a novel approach to
overcome CSPG inhibitory influences, namely, the direct
activation of signaling pathways downstream of integrin.
Materials and Methods
Reagents
LY294001, Wortmannin, K252a, Y27632, BIS, Go6976 and PP1 were from
Calbiochem (San Diego, CA). NGF was obtained from Harlan Bioproducts
(Indianapolis, IN). The specific ILK inhibitor KP-074728 is an analog of the
previously reported KP-392 (Tan et al., 2004). Aggrecan, IGF, EGF and db-cAMP
were from Sigma (St Louis, MO). Transcription inhibitor DRB was from MP
Biomedicals (Irvine, CA). Mouse anti-neurofilament antibody SMI-31 was from
Sternberger/Meyer Immunochemicals (Jarrettsville, MD). Anti-1 integrin (CD29,
clone Ha2/5) was from BD Pharmingen (San Diego, CA). Phospho-GSK-3,
phospho-ERK1/2 and phospho-Akt (Ser473) were all from Cell Signaling
Technology (Beverly, MA). L1 cell adhesion molecule is from R&D Systems
(Minneapolis, MN). All fluorescence-tagged secondary antibodies were from
Molecular Probes (Eugene, OR). Nogo66 peptide was a generous gift from Stephen
Strittmatter (Yale University, New Haven, CT).
Dominant-negative PI3K, dominant-negative C-Raf, GSK-3(S9A), C-EB1 and
C-EB1APC constructs were generated as described previously (Markus et al.,
2002b; Zhou et al., 2004). Dominant-negative Src was a generous gift from David
Shalloway (Cornell University, Ithaca, NY).
Cell culture and immunocytochemistry
L4, L5 and L6 DRGs were dissected from 8- to 12-week-old adult naive or pre-
conditioning lesioned (Liu and Snider, 2001) CF-1 mice and digested with
collagenase (1 mg/ml) for 90 minutes followed by trypsin-EDTA (0.05%) for 15
minutes at 37°C. The DRGs were then washed three times with plating medium
(MEM with L-glutamine and 1 penicillin/streptomycin) plus 5% fetal calf serum
and dissociated with a 1 ml pipette tip in plating medium. Glass coverslips were
coated with poly-D-lysine (100 g/ml), laminin (10 g/ml) with or without
Aggrecan (52 g/ml; Sigma) for 60 minutes before plating. DRGs were plated and
cultured at 37°C in serum-free MEM containing N2 supplement. Embryonic DRG
culture for western blot study was as described in (Zhou et al., 2004).
After 20-24 hours of culture, neurons were fixed in 4% paraformaldehyde for 20
minutes, washed in PBS and blocked in blocking solution (2% BSA, 0.1% Triton
X-100 and 0.1% sodium azide in PBS) for 60 minutes. Coverslips were incubated
with primary monoclonal anti-neurofilament antibody SMI-31 (1:200) for 1 hour,
washed and incubated with goat anti-mouse Alexa Flour 594-conjugated secondary
for 1 hour, washed in distilled H2O and attached to slides with Mowiol antifade
mounting media.
Western blot
Dissociated adult PCL neurons or embryonic neurons were plated on culture dishes
coated with poly-D-lysine or laminin in the absence of NGF. After culture for 3-4
hours, neurons were lysed with lysis buffer and prepared for western blot assay. For
embryonic neurons, cells cultured on laminin were also treated with NGF for 30
minutes before cell lysis.
Gene transfection and pharmacology
DRG neurons were transfected with various DNA constructs using the
electroporation technique from Amaxa (Cologne, Germany). The transfection
procedure was according to the Amaxa protocols for mouse neurons. Briefly,
dissociated neurons were spun down to remove the supernatant completely and












plasmid DNA. Suspended cells were then transferred to a 2.0 mm cuvette and
eletroporated with an Amaxa NucleofectorTM apparatus. After electroporation, cells
were immediately transferred to the desired volume of culture medium and plated
onto coated coverslips. After neurons fully attached to the substrates (2-4 hours),
the medium was changed to remove the remnant transfection buffer.
All growth factors and pharmacological reagents were added directly to the
neuronal culture medium at indicated concentration at the time of plating. For anti-
integrin antibody treatment, cells were incubated with anti-beta1 integrin (20 g/ml)
at 4°C for 30 minutes before plating. Cells were then fixed for analysis following
overnight culture. For each plasmid and pharmacological treatment, at least three
independent experiments were conducted.
Image analysis and statistics
Images were taken with Spot imaging software and a CCD camera (Diagnostic
Instruments) attached to a Nikon Eclipse microscope. A 4 objective (0.45 NA)
was used to record neurons with axons. 10-12 images were acquired for each
coverslip. All image analysis was done with IPLab software. To quantify the
percentages of neurons that grow axons, all cells of each experimental condition
were recorded by the camera. The number of neurons with axons longer than two
cell bodies was then counted. To measure axon length, the first 50-60 neurons with
axons in each condition were selected for measurement. The longest axon of each
neuron was traced manually and the length was then calculated.
All data were reported as mean ± s.e.m., and an unpaired Student’s t-test was
used to determine the significance of the data between groups. For multiple group
comparison, a one-way ANOVA was used followed by a t-test post-hoc analysis.
We would like to thank Sam Snider for help in the data analysis,
and You-Jun Chen for help with western blot experiments. This study
was supported by a Spinal Cord Research Foundation fellowship (to
F.Q.Z.) and NIH grants NS031768 and NS050968 (to W.D.S.).
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